Skip to content

Moxibustion at 'danzhong' (RN17) and 'guanyuan' (RN4) for fatigue symptom in patients with depression - a randomized controlled trial

Moxibustion at 'danzhong' (RN17) and 'guanyuan' (RN4) for fatigue symptom in patients with depression - a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016905
Enrollment
Unknown
Registered
2018-07-02
Start date
2018-07-16
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

control group:Waiting list, after then treated by Moxibustion

Sponsors

Peking University Sixth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients have to meet the criteria of depression episode in ICD-10 (including single depression episode and recurrent depression disorders, excluding bipolar disorder), and the score of thirteenth item in Hamilton depression scale is more than 1 point. Aged 18-60 years male and female; Signed the informed consent and to be able to follow the research program.

Exclusion criteria

Exclusion criteria: 1. Meet any other axial I diagnosis criteria in ICD-10 besides depression episode (single episode or recurrent depression disorder); 2. There were brain organic diseases, head trauma history (loss of consciousness for more than 5 minutes), mental retardation; 3. Having accepted moxibustion in the past 6 months; 4. There is a current risk factor for suicide or serious agitation; 5. Preparing the pregnancy in 3 months, in the pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Reduction rate of fatigue symptom score;

Secondary

MeasureTime frame
Assessment for Depression;

Countries

China

Contacts

Public ContactXu Ke

Peking University Sixth Hospital

xuke0127@163.com+86 010 82806159

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026